CO5011066A1 - Compuestos de triazina - Google Patents

Compuestos de triazina

Info

Publication number
CO5011066A1
CO5011066A1 CO98075403A CO98075403A CO5011066A1 CO 5011066 A1 CO5011066 A1 CO 5011066A1 CO 98075403 A CO98075403 A CO 98075403A CO 98075403 A CO98075403 A CO 98075403A CO 5011066 A1 CO5011066 A1 CO 5011066A1
Authority
CO
Colombia
Prior art keywords
triazine compounds
compound
formula
reduction
preparation
Prior art date
Application number
CO98075403A
Other languages
English (en)
Inventor
Brian Cox
Mark Patrick Healy
Stuart Nobbs Malcolm
Punjabhai Shah Gita
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CO5011066A1 publication Critical patent/CO5011066A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un compuesto de la fórmula (I)y los derivados del mismo aceptables farmacéuticamente.Un proceso para la preparación de un compuesto de la fórmula (I) como se definió en la reivindicación 1, por la reducción de un compuesto de la fórmula (II)
CO98075403A 1997-12-22 1998-12-18 Compuestos de triazina CO5011066A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9726987.2A GB9726987D0 (en) 1997-12-22 1997-12-22 Compounds

Publications (1)

Publication Number Publication Date
CO5011066A1 true CO5011066A1 (es) 2001-02-28

Family

ID=10823992

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98075403A CO5011066A1 (es) 1997-12-22 1998-12-18 Compuestos de triazina

Country Status (34)

Country Link
US (2) US6265405B1 (es)
EP (1) EP1042304A1 (es)
JP (1) JP2001526275A (es)
KR (1) KR20010024800A (es)
CN (1) CN1284951A (es)
AP (1) AP2000001846A0 (es)
AR (1) AR014146A1 (es)
AU (1) AU753874B2 (es)
BR (1) BR9814495A (es)
CA (1) CA2315620A1 (es)
CO (1) CO5011066A1 (es)
EA (1) EA200000561A1 (es)
EE (1) EE200000391A (es)
GB (1) GB9726987D0 (es)
GT (1) GT199800203A (es)
HN (1) HN1998000193A (es)
HR (1) HRP20000419A2 (es)
HU (1) HUP0100611A3 (es)
ID (1) ID25449A (es)
IL (1) IL136867A0 (es)
IS (1) IS5542A (es)
JO (1) JO2065B1 (es)
MA (1) MA26587A1 (es)
NO (1) NO20003211L (es)
NZ (1) NZ505254A (es)
PA (1) PA8465101A1 (es)
PE (1) PE20000063A1 (es)
PL (1) PL341392A1 (es)
SK (1) SK9592000A3 (es)
SV (1) SV1998000151A (es)
TR (1) TR200001970T2 (es)
WO (1) WO1999032462A1 (es)
YU (1) YU39600A (es)
ZA (1) ZA9811725B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0002666D0 (en) 2000-02-04 2000-03-29 Univ London Blockade of voltage dependent sodium channels
US6897319B2 (en) * 2001-12-27 2005-05-24 Ortho-Mcneil Pharmaceutical, Inc. Useful aroyl pyrrole heteroaryl methanones and methanols
JP4744142B2 (ja) * 2002-07-29 2011-08-10 グラクソ グループ リミテッド ラモトリギンを含む徐放性処方
CA2514574A1 (en) * 2003-01-30 2004-08-12 Dynogen Pharmaceuticals, Inc. Use of sodium channel modulators for treating gastrointestinal tract disorders
MY142651A (en) 2003-03-18 2010-12-15 Merck Sharp & Dohme Biaryl substituted triazoles as sodium channel blockers
DE10332472A1 (de) * 2003-07-16 2005-02-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung von Tinnitus
CA2536764C (en) * 2003-08-25 2013-09-17 Newron Pharmaceuticals, S.P.A. .alpha.-aminoamide derivatives useful as anti-inflammatory agents
US20060115865A1 (en) * 2004-10-25 2006-06-01 Anlong Ouyang Lamotrigine analogs
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions
ES2770143T3 (es) * 2018-02-13 2020-06-30 Fis Fabbrica Italiana Sintetici Spa Nuevo procedimiento eficiente para la preparación de sitagliptina
CN114796146B (zh) * 2022-04-28 2023-03-28 上海奥科达医药科技股份有限公司 一种拉莫三嗪的缓释制剂及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637688A (en) 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
JPS5625170A (en) 1979-06-01 1981-03-10 Wellcome Found Triazine derivative
EP0059987B1 (en) 1979-06-01 1985-08-14 The Wellcome Foundation Limited Alpha-cyano-alpha-((n-guanidino)-imino) toluenes
EP0086502B1 (en) 1979-08-16 1987-03-25 The Wellcome Foundation Limited Substituted aromatic triazines
GB8328757D0 (en) 1983-10-27 1983-11-30 Wellcome Found Chemical compounds
GB9012316D0 (en) 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
GB9012312D0 (en) 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
GB9012311D0 (en) 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
GB9203483D0 (en) 1992-02-19 1992-04-08 Wellcome Found Anti-inflammatory compounds
WO1993025207A1 (en) 1992-06-12 1993-12-23 The Wellcome Foundation Limited Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine isethionate for the treatment and prevention of dependence, tolerance and sensitization of drugs
WO1994014780A1 (en) 1992-12-18 1994-07-07 The Wellcome Foundation Limited Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors
GB9305692D0 (en) 1993-03-19 1993-05-05 Wellcome Found Therapeutic triazine compounds and use
US5866597A (en) 1993-03-19 1999-02-02 Glaxo Wellcome Inc. Use of triazine compounds for the treatment of memory and learning disorders
GB9426448D0 (en) * 1994-12-30 1995-03-01 Wellcome Found Process
FR2741879A1 (fr) 1995-12-05 1997-06-06 Esteve Labor Dr Derives de fluorophenyl-triazines et pyrimidines, leur preparation et leur application en tant que medicament

Also Published As

Publication number Publication date
SK9592000A3 (en) 2001-03-12
AU2414799A (en) 1999-07-12
WO1999032462A1 (en) 1999-07-01
GB9726987D0 (en) 1998-02-18
SV1998000151A (es) 1999-07-05
IL136867A0 (en) 2001-06-14
EE200000391A (et) 2002-02-15
BR9814495A (pt) 2000-10-10
US6465461B1 (en) 2002-10-15
CN1284951A (zh) 2001-02-21
AP2000001846A0 (en) 2000-06-30
HRP20000419A2 (en) 2000-12-31
PL341392A1 (en) 2001-04-09
JO2065B1 (en) 2000-05-21
PE20000063A1 (es) 2000-02-16
AR014146A1 (es) 2001-02-07
HN1998000193A (es) 2000-04-05
HUP0100611A3 (en) 2003-03-28
MA26587A1 (fr) 2004-12-20
NZ505254A (en) 2002-06-28
CA2315620A1 (en) 1999-07-01
IS5542A (is) 2000-06-20
EP1042304A1 (en) 2000-10-11
YU39600A (sh) 2002-11-15
NO20003211D0 (no) 2000-06-21
TR200001970T2 (tr) 2001-01-22
GT199800203A (es) 2000-06-14
KR20010024800A (ko) 2001-03-26
AU753874B2 (en) 2002-10-31
ZA9811725B (en) 2000-06-27
ID25449A (id) 2000-10-05
NO20003211L (no) 2000-08-21
US6265405B1 (en) 2001-07-24
HUP0100611A2 (hu) 2001-09-28
PA8465101A1 (es) 2000-09-29
EA200000561A1 (ru) 2001-04-23
JP2001526275A (ja) 2001-12-18

Similar Documents

Publication Publication Date Title
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
UY26495A1 (es) " derivados de tiazolilamida"
TR200102800T2 (tr) Yeni bileşikler.
ES2134226T3 (es) Derivados de s-triazina como fotoestabilizadores.
MX9304819A (es) Nuevos derivados de xantina y procedimiento para su preparacion.
MX9709867A (es) Derivados de pirimidina condensados con un anillo heterociclico, composiciones que contienen los mismos, y uso de los mismos.
YU69902A (sh) Novi derivati piperazina
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
MY126559A (en) Fungicidal 2-methoxybenzophenones
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
DE69027235D1 (de) Xanthinderivate
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
CO5011066A1 (es) Compuestos de triazina
BR0109542A (pt) Derivados de imidazopirina alquilados
YU30603A (sh) Derivati premošćenog piperazina
TR200001452T2 (tr) Bifenilamidin türevleri.
TR199700206A2 (xx) Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
DK0842165T3 (da) Thiazolidin-4-carboxylsyrederivater som cytobeskyttende midler
IS4367A (is) CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín
ES2185196T3 (es) Un procedimiento para la preparacion de tetraazamacrociclos.
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
ES2166045T3 (es) Procedimiento para la preparacion de compuestos de 4,6-bis(ariloxi)pirimidina asimetricos.
AR027349A1 (es) Derivados de amidas heterociclicas
ES2195500T3 (es) Dereivados del 2-indanometanol y su utilizacion a titulo de ingredientes perfumantes.
ES2141948T3 (es) Derivados de ciclohexanona, procedimiento para su preparacion y productos intermedios del procedimiento.